PEPCK is the main rate limiting enzyme of gluconeogenesis, our results showed that the expression of PEPCK was increased in T2DM–NAFLD rat, contributing to hepatic gluconeogenesis, these changes can be attenuated by administration of bicyclol. Here, PCK2 is linked to metabolic dysfunction-associated steatotic liver disease.